There are 2789 resources available
1833P - Chemobrain: Seldom studied or reported, but apparently very common
Presenter: Isabelle Huet
Session: ePoster Display
1867P - An overview of RAD51C pathogenic variants in Mexican patients with breast cancer
Presenter: Javier Castorena Ibarra
Session: ePoster Display
1868P - Real-world safety of the 6-weekly pembrolizumab regimen in cancer patients treated in South East London
Presenter: Matthaios Kapiris
Session: ePoster Display
1869TiP - A phase II, multicenter, open-label study evaluating trastuzumab deruxtecan (T-DXd) for the treatment of select HER2-expressing solid tumors (DESTINY-PanTumor02)
Presenter: Funda Meric-Bernstam
Session: ePoster Display
1837P - Comprehensive genomic profiling of SMARCA2/4 alterations in Chinese pan-cancer patients (pts) identified by next generation sequencing (NGS)
Presenter: Jiayong Liu
Session: ePoster Display
1838P - Germline mutations in homologous recombination repair (HRR) pathway in a Chinese multi-cancer retrospective analysis
Presenter: Linlin Zhang
Session: ePoster Display
1839P - Infectious complications post-cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A meta-analysis
Presenter: Akhil Jain
Session: ePoster Display
1840P - Impact of age, comorbidities and polypharmacy on survival in advanced cancers
Presenter: David Dawe
Session: ePoster Display
1841P - Retrospective review of frailty in lung cancer patients
Presenter: Meera Chauhan
Session: ePoster Display
1842P - Molecular testing in older patients treated for an advanced or metastatic non-squamous non-small cell lung cancer
Presenter: Tina Lamy
Session: ePoster Display